22nd Annual Congress of International Drug Discovery Science & Technology (IDDST 2026)

The 22nd Annual Congress of International Drug Discovery Science & Technology (IDDST 2026) showcases innovations in drug discovery, covering target identification, biotechnology, small molecules, natural products, and translational development.

Key Topics

• Drug Target Discovery and Validation
• Drug Discovery Biology and Biotechnology
• Rational Drug Design
• Drug Screening Technology
• Early Phase Drug Discovery-Upstream
• Leading Drug Discovery Technology
• Breaking Biotherapy Discovery
• Frontier in Small Molecule Drug Discovery
• Traditional Chinese Medicine vs Natural Product based Drug Discovery
• Genome-Based Drug Discovery and Development
• Pipeline Update on IND against Major Diseases
• Late Phase Drug Discovery -Downstream
• New Drug Bioprocess and Production under GMP Standards
• Me-too Drug Discovery and Biosimilar
• Drug Discovery Integrative Services, Deal-Making, and Business Development
• Key Issues in IND Filing and Regulatory Approval Process
• Non-Human Drug Discovery
• Pharmaceutical R & D Management and Translational Sciences
• Pesticide Discovery and Development
• Veterinary Medicine Discovery and Development
• Aquaculture Biocides and Disease Prevention Drug Discovery

Who should Attend

Scientists and decision makers responsible for: Preclinical Development, R&D Discovery Development, Pharmaceutical Development, Screening Research, Product Development, Scientific Affairs Toxicology, Technology, Safety, Genetics, Chemistry and Medical Affairs.